WENTWORTH KORY JAMES (Chief Financial Officer) sold 5.5% of their position (7.99K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $97.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0001725663-26-000002
Officer· Chief Financial Officer
Since Oct 2021
-7.99K
Net shares
Net seller
$97.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.99K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.99K
Price / share
$12.25
Trade value
$97.89K
% of position
5.5%
3/4/2026
145.97K→137.99K
Total
Net shares
−7.99K
Net value
-$97.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | S · Sale | −7.99K | $12.25 | $97.89K | 5.5% | 145.97K | 137.99K |
| Total | −7.99K | -$97.89K | ||||||
Derivative Transactions0
No derivative transactions reported